Shusuan Jiang

机构：Hunan Cancer Hospital

发表论文 51 篇 · 总被引 842 次 · h-index 13

代表论文

• Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial (2024 · Journal of Clinical Oncology · 被引 162)
• ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer (2025 · New England Journal of Medicine · 被引 123)
• Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer (2025 · New England Journal of Medicine · 被引 79)
• Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study (2025 · Annals of Oncology · 被引 39)
• Efficacy and safety of sacituzumab tirumotecan monotherapy in patients with advanced urothelial carcinoma who progressed on or after prior anti-cancer therapies: Report from the phase 1/2 MK-2870-001 study. (2025 · Journal of Clinical Oncology · 被引 12)
• TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study (2025 · Cancer Cell · 被引 10)